Wednesday, September 23, 2026

Halozyme Therapeutics, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

January 6, 2021

Halozyme Therapeutics, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Green Dot Corporation

5.3% sales growth and 5.05% return on equity

Green Dot Corporation operates as a financial technology and bank holding company in the United States.

Green Dot Corporation's sales growth this year is anticipated to be 12.5% and 3.7% for next year.

Year-on-year quarterly revenue growth grew by 21.1%, now sitting on 1.22B for the twelve trailing months.

Green Dot Corporation's sales growth for the next quarter is 5.3%. The company's growth estimates for the current quarter and the next is 28.6% and negative -3.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.05%.

Volatility

Green Dot Corporation's last day, last week, and last month's average volatility was a negative 2.86%, a negative 1.46%, and a negative 0.26%, respectively.

Green Dot Corporation's last day, last week, and last month's high and low average amplitude percentage was 5.51%, 4.01%, and 4.37%, respectively.

Green Dot Corporation's Stock Yearly Top and Bottom Value

Green Dot Corporation's stock is valued at $53.19 at 19:22 EST, way under its 52-week high of $64.97 and way above its 52-week low of $14.20.

Green Dot Corporation's Moving Average

Green Dot Corporation's worth is below its 50-day moving average of $55.45 and higher than its 200-day moving average of $52.93.

2. Halozyme Therapeutics, Inc.

281.6% sales growth and 12.5% return on equity

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally.

Halozyme Therapeutics, Inc.'s sales growth this year is expected to be 35.4% and 52.2% for next year.

Year-on-year quarterly revenue growth grew by 41.3%, now sitting on 199.56M for the twelve trailing months.

Halozyme Therapeutics, Inc.'s sales growth for the next quarter is 281.6%. The company's growth estimates for the current quarter and the next is 316.7% and 1025%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.5%.

Volatility

Halozyme Therapeutics, Inc.'s last day, last week, and last month's average volatility was 0.28%, 0.03%, and 0.24%, respectively.

Halozyme Therapeutics, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 3.74%, 3.08%, and 3.96%, respectively.

Halozyme Therapeutics, Inc.'s Stock Yearly Top and Bottom Value

Halozyme Therapeutics, Inc.'s stock is valued at $42.71 at 19:22 EST, under its 52-week high of $44.53 and way higher than its 52-week low of $12.71.

Halozyme Therapeutics, Inc.'s Moving Average

Halozyme Therapeutics, Inc.'s value is above its 50-day moving average of $40.97 and way above its 200-day moving average of $31.28.

3. PayPal

21.3% sales growth and 17.95% return on equity

PayPal Holdings, Inc. operates as a technology platform and digital payments company that enables digital and mobile payments on behalf of consumers and merchants worldwide.

PayPal's sales growth this year is expected to be 20.6% and 18.6% for next year.

Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 20.3B for the twelve trailing months.

PayPal's sales growth for the next quarter is 21.3%. The company's growth estimates for the current quarter and the next is 15.1% and 48.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.95%.

Volatility

PayPal's last day, last week, and last month's average volatility was a negative 0.98%, a negative 0.57%, and a positive 0.42%, respectively.

PayPal's last day, last week, and last month's high and low average amplitude percentage was 4.60%, 2.96%, and 2.71%, respectively.

PayPal's Stock Yearly Top and Bottom Value

PayPal's stock is valued at $234.91 at 19:22 EST, under its 52-week high of $244.25 and way higher than its 52-week low of $82.07.

PayPal's Moving Average

PayPal's worth is above its 50-day moving average of $218.47 and way above its 200-day moving average of $196.41.

Previous days news about PayPal

According to Business Insider on Saturday, 2 January, "Companies like PayPal added support for cryptocurrency transactions, and some retail investors turned to digital coins as a safe haven (like gold) during the coronavirus pandemic."

According to Business Insider on Monday, 4 January, "It's an equity-based fund, though some of its holdings, such as Square (NYSE:SQ) and PayPal (NASDAQ:PYPL), are increasingly levered to the crypto trade."

According to Business Insider on Monday, 4 January, "Happy Returns has raised $25 million in venture capital from investors including Upfront Ventures and PayPal Ventures."

According to Bloomberg Quint on Tuesday, 5 January, "Its businesses range from ride-hailing and payments to online shopping and delivery -- a local mashup of Uber Technologies Inc., PayPal Holdings Inc., Amazon.com Inc., and DoorDash Inc. It plans to go public in the U.S. and Indonesia."

According to Bloomberg Quint on Tuesday, 5 January, "Divvy, the financial-technology company that offers corporate cards and expense-management software to small businesses, said it's now valued at $1.6 billion after raising money from investors including PayPal Holdings Inc."

According to Bloomberg Quint on Tuesday, 5 January, "The company will offer as much as $180 in credits for purchases made through PayPal with the $550-a-year consumer Platinum card, and up to $1,700 in credits for virtual personal training with luxury-gym chain Equinox, car rentals with Avis Budget Group Inc., purchases on Home Depot Inc.'s website and spending with other retailers."

According to Bloomberg Quint on Tuesday, 5 January, "Affirm was founded in 2012 by Max Levchin, who also co-founded PayPal Holdings Inc. Levchin is the company's single biggest shareholder, according to the filing. "

4. BancFirst Corporation

7% sales growth and 9.86% return on equity

BancFirst Corporation operates as the bank holding company for BancFirst that provides a range of commercial banking services to retail customers, and small to medium-sized businesses.

BancFirst Corporation's sales growth this year is expected to be 5.2% and a negative 1.7% for next year.

Year-on-year quarterly revenue growth declined by 12.8%, now sitting on 379.33M for the twelve trailing months.

BancFirst Corporation's sales growth for the next quarter is 7%. The company's growth estimates for the present quarter and the next is a negative 32.1% and 42.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.86%.

Volatility

BancFirst Corporation's last day, last week, and last month's average volatility was 1.08%, 0.15%, and 0.36%, respectively.

BancFirst Corporation's last day, last week, and last month's high and low average amplitude percentage was 3.01%, 2.58%, and 3.24%, respectively.

BancFirst Corporation's Stock Yearly Top and Bottom Value

BancFirst Corporation's stock is valued at $58.70 at 19:22 EST, below its 52-week high of $63.96 and way higher than its 52-week low of $26.00.

BancFirst Corporation's Moving Average

BancFirst Corporation's worth is above its 50-day moving average of $56.47 and way above its 200-day moving average of $46.02.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com